Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): follow-up analysis of a randomised, phase 3 study

1. Richardson, P.G.
2. Perrot, A.
3. San-Miguel, J.
4. Beksac, M.
5. Spicka, I.
6. Leleu, X.
7. Schjesvold, F.
8. Moreau, P.
9. Dimopoulos, M.A.
10. Huang, J.S.-Y.
11. Minarik, J.
12. Cavo, M.
13. Prince, H.M.
14. Malinge, L.
15. Dubin, F.
16. van de Velde, H.
17. Anderson, K.C.